Usage of plasma-derived factor VIII-von willebrand factor concentrate, recombinant factor VIII and factor IX concentrates in Tasmania

Pathology ◽

10.1016/j.pathol.2017.12.305 ◽

2018 ◽

Vol 50 ◽

pp. S108 ◽

Cited By ~ 1

Author(s):

Xuan Ni Tan ◽

Sam Hitchins ◽

Archna Sharma

Keyword(s):

Factor Viii ◽

Von Willebrand Factor ◽

Factor Ix ◽

Recombinant Factor Viii ◽

Factor Concentrate ◽

Von Willebrand ◽

Willebrand Factor

Download Full-text

Phospholipid binding lowers immunogenicity of human recombinant factor VIII in von Willebrand factor knockout mice

Thrombosis and Haemostasis ◽

10.1160/th10-09-0628 ◽

2011 ◽

Vol 105 (06) ◽

pp. 1115-1118 ◽

Cited By ~ 1

Author(s):

Dipak Pisal ◽

Sathy Balu-Iyer

Keyword(s):

Factor Viii ◽

Von Willebrand Factor ◽

Knockout Mice ◽

Recombinant Factor Viii ◽

Phospholipid Binding ◽

Von Willebrand ◽

Willebrand Factor

Download Full-text

Clinical and biological evaluation in von Willebrand's disease of a von Willebrand factor concentrate with low factor VIII activity

British Journal of Haematology ◽

10.1111/j.1365-2141.1992.tb08903.x ◽

1992 ◽

Vol 80 (2) ◽

pp. 214-221 ◽

Cited By ~ 37

Author(s):

J. Goudemand ◽

C. Mazurier ◽

A. Marey ◽

C. Caron ◽

B. Coupez ◽

...

Keyword(s):

Factor Viii ◽

Von Willebrand Factor ◽

Biological Evaluation ◽

Factor Viii Activity ◽

Von Willebrand's Disease ◽

Von Willebrand’S Disease ◽

Factor Concentrate ◽

Von Willebrand ◽

Willebrand Factor

Download Full-text

Pharmacokinetic profile of Optivate ® (high‐purity factor VIII/von Willebrand factor concentrate) in treating von Willebrand disease

Haemophilia ◽

10.1111/hae.12843 ◽

2015 ◽

Vol 22 (1) ◽

Author(s):

R. Shaikh‐Zaidi ◽

A. Lubetsky ◽

A. Inbal ◽

C. Dash

Keyword(s):

Factor Viii ◽

Von Willebrand Factor ◽

High Purity ◽

Pharmacokinetic Profile ◽

Von Willebrand Disease ◽

Factor Concentrate ◽

Von Willebrand ◽

Willebrand Factor

Download Full-text

Efficacy and safety of a factor VIII-von Willebrand factor concentrate 8Y: stability, bacteriological safety, pharmacokinetic analysis and clinical experience

Haemophilia ◽

10.1046/j.1365-2516.2002.00673.x ◽

2002 ◽

Vol 8 (5) ◽

pp. 622-628 ◽

Cited By ~ 8

Author(s):

A. Lubetsky ◽

U. Martinowitz ◽

J. Luboshitz ◽

G. Kenet ◽

N. Keller ◽

...

Keyword(s):

Factor Viii ◽

Clinical Experience ◽

Von Willebrand Factor ◽

Pharmacokinetic Analysis ◽

Efficacy And Safety ◽

Factor Concentrate ◽

Von Willebrand ◽

Willebrand Factor

Download Full-text

Factor VIII/von Willebrand factor concentrate therapy for ventricular assist device-associated acquired von Willebrand disease

Transfusion ◽

10.1111/j.1537-2995.2011.03500.x ◽

2012 ◽

Vol 52 (7) ◽

pp. 1535-1541 ◽

Cited By ~ 21

Author(s):

Melissa Cushing ◽

Kathy Kawaguchi ◽

Kenneth D. Friedman ◽

Tomer Mark

Keyword(s):

Factor Viii ◽

Von Willebrand Factor ◽

Ventricular Assist Device ◽

Von Willebrand Disease ◽

Assist Device ◽

Ventricular Assist ◽

Acquired Von Willebrand Disease ◽

Factor Concentrate ◽

Von Willebrand ◽

Willebrand Factor

Download Full-text

Higher recovery of factor VIII (FVIII) with intermediate FVIII/von Willebrand factor concentrate than with recombinant FVIII in a haemophilia A patient with an inhibitor

Haemophilia ◽

10.1111/j.1365-2516.2006.01182.x ◽

2006 ◽

Vol 12 (1) ◽

pp. 110-113 ◽

Cited By ~ 24

Author(s):

T. INOUE ◽

M. SHIMA ◽

M. TAKEYAMA ◽

T. MATSUMOTO ◽

K. NISHIYA ◽

...

Keyword(s):

Factor Viii ◽

Von Willebrand Factor ◽

Haemophilia A ◽

Recombinant Fviii ◽

Factor Concentrate ◽

Von Willebrand ◽

Willebrand Factor

Download Full-text

Functional Characterisation of a von Willebrand Factor Concentrate with Low Factor VIII Content - Multimeric and Flow Chamber Analysis and a Case Report

10.1055/s-0039-1680231 ◽

2019 ◽

Author(s):

T. Kragh ◽

M. Spannagl ◽

I. Pekrul

Keyword(s):

Case Report ◽

Factor Viii ◽

Von Willebrand Factor ◽

Flow Chamber ◽

Functional Characterisation ◽

Factor Concentrate ◽

Von Willebrand ◽

Willebrand Factor

Download Full-text

Pharmacokinetic studies on Wilfactin®, a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methods

Journal of Thrombosis and Haemostasis ◽

10.1111/j.1538-7836.2005.01435.x ◽

2005 ◽

Vol 3 (10) ◽

pp. 2219-2227 ◽

Cited By ~ 50

Author(s):

J. GOUDEMAND ◽

I. SCHARRER ◽

E. BERNTORP ◽

C. A. LEE ◽

A. BOREL-DERLON ◽

...

Keyword(s):

Factor Viii ◽

Von Willebrand Factor ◽

Pharmacokinetic Studies ◽

Virus Inactivation ◽

Factor Concentrate ◽

Von Willebrand ◽

Willebrand Factor

Download Full-text

Acquired von Willebrand factor deficiency during high-dose infusion of recombinant factor VIII

British Journal of Haematology ◽

10.1046/j.1365-2141.1996.d01-1683.x ◽

1996 ◽

Vol 93 (3) ◽

pp. 684-687 ◽

Cited By ~ 16

Author(s):

G. ROCK ◽

T. Adamkiewicz ◽

V. Blanchette ◽

A. Poon ◽

C. Sparling

Keyword(s):

Factor Viii ◽

Von Willebrand Factor ◽

Recombinant Factor Viii ◽

High Dose ◽

Factor Deficiency ◽

Dose Infusion ◽

Von Willebrand ◽

Willebrand Factor

Download Full-text

Characterization of protein unable to bind von Willebrand factor in recombinant factor VIII products

Journal of Thrombosis and Haemostasis ◽

10.1111/jth.15257 ◽

2021 ◽

Author(s):

Haarin Chun ◽

John R. Pettersson ◽

Svetlana A. Shestopal ◽

Wells W. Wu ◽

Ekaterina S. Marakasova ◽

...

Keyword(s):

Factor Viii ◽

Von Willebrand Factor ◽

Recombinant Factor Viii ◽

Von Willebrand ◽

Willebrand Factor

Download Full-text